Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure

Abstract
No abstract available
Funding Information
  • Scientific Research (JP17K15979, JP17K10137, JP17H04758, 18H03187)
  • Challenging Exploratory Research (19K22791)
  • Japan Foundation for Applied Enzymology
  • Hokkaido Heart Association
  • MSD Life Science Foundation
  • Uehara Memorial Foundation
  • Cardiovascular Research Fund, Tokyo, Japan
  • Fukuda Memorial Foundation for Medical Research
  • Kimura Memorial Heart Foundation Research
  • SENSHIN Medical Research Foundation
  • Nakatomi Foundation
  • Japan Heart Foundation
  • Japan Science Society
  • Japan Science and Technology Agency
  • Boehringer Ingelheim
  • Boehringer Ingelheim

This publication has 49 references indexed in Scilit: